American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARA | USPH | DXR | ||
| Company | American Renal Associates | U.S. Physical Therapy | Daxor Corp | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | ||
| Open | 11.48 | 63.05 | 10.20 | ||
| High | 11.52 | 63.07 | 10.92 | ||
| Low | 11.33 | 61.00 | 10.20 | ||
| Latest | 11.52 | 61.96 | 10.82 | ||
| Change | +0.02 | -0.43 | -0.53 | ||
| % Change | +0.17% | -0.69% | -4.67% | ||
| Volume | 9,800 | 140,000 | 2,800 | ||
| 20-Day Average Volume | 110,105 | 265,145 | 9,540 | ||
| Previous Close | 11.50 | 62.39 | 11.35 | ||
| Industry | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 11.47 | 65.85 | 10.55 | ||
| 20-Day Raw Stochastic | 100.00% | 21.32% | 53.56% | ||
| 20-Day Relative Strength | 70.89 | 37.93 | 52.31 | ||
| Weighted Alpha | -7.72 | -27.82 | +21.82 | ||
| Today's Opinion | 100% Buy | 100% Sell | 40% Sell | ||
| Previous Opinion | 100% Buy | 100% Sell | 40% Sell | ||
| Last Month's Opinion | 72% Buy | 100% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.44% since 01/15/21 | -1.35% since 05/15/26 | +3.05% since 05/12/26 | ||
| Low | 11.33 on 01/25/21 | 60.35 on 05/20/26 | 10.20 on 05/21/26 | ||
| High | 11.52 on 01/25/21 | 65.80 on 05/18/26 | 11.74 on 05/20/26 | ||
| 1-Month | |||||
| %Chg | +0.70% since 12/24/20 | -17.96% since 04/22/26 | +9.85% since 04/21/26 | ||
| Low | 11.33 on 01/25/21 | 58.19 on 05/08/26 | 9.10 on 05/07/26 | ||
| High | 11.52 on 01/25/21 | 76.71 on 04/23/26 | 12.31 on 04/28/26 | ||
| 3-Month | |||||
| %Chg | +0.17% since 10/23/20 | -27.18% since 02/20/26 | -11.38% since 02/20/26 | ||
| Low | 11.33 on 01/25/21 | 58.19 on 05/08/26 | 8.56 on 04/08/26 | ||
| High | 11.52 on 01/25/21 | 85.31 on 02/23/26 | 12.36 on 02/24/26 | ||
| 6-Month | |||||
| %Chg | +80.56% since 07/24/20 | -13.50% since 11/21/25 | -17.99% since 11/21/25 | ||
| Low | 6.08 on 09/21/20 | 58.19 on 05/08/26 | 8.56 on 04/08/26 | ||
| High | 11.98 on 10/06/20 | 90.94 on 02/12/26 | 14.76 on 12/29/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 397,935 | 942,969 | 54,518 | ||
| Shares Outstanding, K | 34,543 | 15,219 | 5,039 | ||
| Annual Sales | 822,520,000 | 780,990,000 | 1,450,000 | ||
| Annual Net Income | -13,790,000 | 39,580,000 | -7,190,000 | ||
| Last Quarter Sales | 209,690,000 | 198,290,000 | 342,584 | ||
| Last Quarter Net Income | -2,690,000 | 5,040,000 | -1,491,188 | ||
| 60-Month Beta | 1.11 | 1.21 | 0.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.46 on 05/06/26 | N/A | ||
| Earnings Date | 03/15/21 | 08/05/26 | 03/06/25 | ||
| Most Recent Dividend | N/A | 0.460 on 05/22/26 | 0.030 on 01/05/18 | ||
| Next Ex-Dividends Date | N/A | 05/22/26 | 01/05/18 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 24.17 | 0.00 | ||